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Abstract Propynyl, hexynyl and t-butylethynyl diethyl phos- 
phates were found to be very powerful covalent inhibitors of 
serine enzymes. Esterases were inhibited with second-order rate 
constants of 107-10 s M - I  min -1. Most proteases were inhibited 
with a rate constant of 104-10 s M - r  min -1. By inhibiting 
chymotrypsin with (3-14C)-l-propynyl diethyl phosphate, it was 
established that inhibition was caused by binding of the 
phosphate group to the enzyme active site. 
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1. Introduction 
Enzyme inhibitors find wide applications in a variety of 
ar:as. Anticholinesterase phosphate and carbamate deriva- 
tixes are extensively used as pesticides [1,2]. Inhibitors of es- 
te~ases and proteases are applied as chemotherapeutic drugs. 
In some cases the unregulated activity of an enzyme can lead 
to accumulation of undesirable products or to decomposition 
of vital metabolites, which has pathological effects. Inhibitors 
of the enzyme involved can serve as drugs which alleviate the 
pathological results. For example, glaucoma nd Alzheimer's 
di-,ease are treated with acetylcholinesterase (ACHE) inhibitors 
which reduce the activity of the enzyme so that acetylcholine 
co acentration is increased and reduces the pathological effects 
[341. 
Studies of inhibitor interactions with enzymes are of impor- 
ta~ce for the design of drugs for therapeutic application. 
few years ago we showed that the alkynyl esters propynyl 
be.qzoate and propynyl methoxybenzoate reacted with a vari- 
et', rof proteases and esterases forming a relatively stable acyl- 
enzyme intermediate so that the enzymes were practically in- 
hi~fited [5]. 
~_s many 'actiw" phosphates are generally good inhibitors 
ot proteases and e~terases, it was of interest to study the 
in eraction of the new types of compounds alkynyl phos- 
phates [6,7] with a variety of enzymes. 
l-Propynyl diethyl phosphate (PDEP, I), 1-hexynyl diethyl 
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phosphate (HDEP, II) and 1-t-butylethynyl dieth.yl phosphate 
(t-BEDEP, III) were found to be very potent inhibitors of 
serine enzymes. Chymotrypsin, for instance, was inhibited 
with a rate constant of 105 M -1 min -1, while AChE was 
inhibited with a rate constant of 4× 107 M -1 min -1. These 
rate constants are higher than those found for other powerful 
inhibitors of the above-mentioned nzymes. 
CH3C =- C-O-P(O)(OC2H5)2 I 
CH3(CH2)3  C ~ C-O-P(O)(OC2H5)2 II 
(CH3)3CC --- C-O-P(O)(OC2H5)2 III 
Alkynyl phosphates can react with serine enzymes via dif- 
ferent pathways: 
(1) A phosphorylation f the serine group at the active site 
(Scheme 1). 
H20 
EOH + RC---COP(O)(OC2Hs)2 --~ EOP(O)(OC2Hs)2 + RCH2COOH 
EOH designates the serine nzyme. 
Scheme 1. 
(2) Previous studies suggested that in some cases alkynyl 
esters behave as suicide substrates. Thus, pig liver esterase 
started to hydrolyze propynyl benzoate quite rapidly, but 
the rate slowed down during the course of the reaction and 
eventually stopped when a portion of the substrate was still 
not affected by the enzyme [5]. Raushel and Stang and cow- 
orkers [8,9] studied the reaction of phosphotriesterase with 
alkynyl phosphate sters and demonstrated that the ester 
was a good substrate of the enzyme but the product formed 
inhibited the enzyme. It was concluded that the 'lalent' ketene 
in the alkynyl group is liberated by hydrolysis and inhibits the 
enzyme. Thus the inhibition is of a mechanism-based type 
(Scheme 2). 
EXH + RC----CO-P(O)(OC2H~)2 ---> EXH + HO-P(O)(OC2H~)2 + RCH=C=O 
EXH + RCH=C=O -+ EX-C(O)CH2R 
X denotes a nueleophilie group on the enzyme. 
Scheme 2. 
(3) Theoretically, a nucleophile can add to the alkynyl triple 
bond forming a covalent adduct which is enzymatically inac- 
tive (Scheme 3). 
H20 
EXH + RC---COP(O)(C2H~)= --> EX-C=CHOP(O)(OC=H~)2 
R 
Scheme 3. 
It was of interest o establish which of the above mechan- 
isms was operative in our study of enzymic inhibition. To this 
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end we treated tx-chymotrypsin (CT) with PDEP labeled with 
]4C at the propynyl moiety and found that practically no 
radioactivity was bound to the enzyme, indicating that the 
phosphate and not the alkynyl group was responsible for 
the covalent inhibition. 
2. Materials and methods 
Enzymes were purchased from Worthington and Sigma. Substrates 
were obtained from Sigma. The inhibitors PDEP, HDEP and t-BE- 
DEP were prepared according to Stang et al. [6,7]. 3-14C-labeled 
PDEP [8] was prepared with a specific activity of 0.17 mCi/mmol. 
2.1. Enzymic reactions 
The activities of chymotrypsin (CT), subtilisin and proteinase K
were determined with acetyltyrosine ethyl ester (ATEE) and those 
of trypsin, plasmin, kallikrein and thrombin were assayed with ben- 
zoylarginine ethyl ester (BAEE). The activity of elastase was estimated 
by using benzyloxycarbonyl-L-alanine p-nitrophenyl ester (Z-Ala- 
pNP). Pig liver esterase was assayed with ethyl butyrate and choles- 
terol esterase and lipase were assayed using p-nitrophenyl decanoate 
as a substrate. Enzymic activity was generally followed in the pH stat 
at pH 8, 25°C in the presence of 0.1 M NaC1. Hydrolysis of the 
chromogenic p-nitrophenyl ester substrates (0.1 mM) was monitored 
spectrophotometrically t 400 nm. The activities of AChE and butyr- 
ylcholinesterase (BChE) were determined by the method of Ellman et 
al. [10] using acetylthiocholine iodide and butyrylthiocholine iodide, 
respectively, as substrates. 
For conducting the inhibition experiments a stock solution (1-10 
mM) of the alkynyl phosphate dissolved in acetonitrile was prepared 
and a measured amount of the solution was added to an enzyme 
solution (0.05-1 mg/ml) at pH 8 (0.1 M phosphate buffer) 25°C. 
The final inhibition mixture contained 5% (v/v) acetonitrile. At timed 
intervals an aliquot of the reaction mixture was removed and added to 
a substrate solution and the enzymic activity followed. From the 
residual activity as a function of time the rate constant of inhibition 
was calculated. In order to estimate the rate constant for very fast 
reactions, we used the method of competitive covalent inhibition of 
the enzyme in the presence of a substrate [11]. 
2.2. Determination of active site concentration by titration 
To several vials containing the same amount of enzyme in 0.1 M 
phosphate buffer, pH 8 and 25°C, we added increasing amounts of 
alkynyl phosphate. The residual activity was assessed at different 
times until it remained unchanged. The loss of enzymic activity was 
proportional to the amount of alkynyl phosphate added, and the 
minimal concentration of the ester that abolished activity was equiva- 
lent to the active enzyme concentration. 
2.3. Radioactive labeling of chymotrypsin 
In order to elucidate the mechanism by which alkynyl phosphates 
inhibit enzymes we treated CT with (3J4C)-l-propynyl diethyl phos- 
phate. 
One milligram of CT (40 nmol) was dissolved in 1.0 ml of phos- 
phate buffer, pH 8.14C-labeled PDEP was dissolved in acetonitrile to 
a concentration of 12 mM (determined by radioactivity counting). 
Five microliters of this solution was added to the enzyme solution 
(50% molar excess of PDEP). After 5 min (a period of time sufficient 
for complete inhibition) 2 ml of cold 25% trichloroacetic acid (TCA) 
was added to the reaction mixture and it was placed on ice for 30 min. 
A precipitate of the protein formed and was then filtered through a 
GF/C glass-fiber filter. The filtrate was saved, and the precipitate on 
the filter was thoroughly washed with 10 ml of 8% cold TCA. The 
glass-fiber filter containing the precipitate was dried under a lamp, 
inserted in 3 ml Opti-Fluor liquid scintillation cocktail (Packard) 
and the radioactivity determined in a Packard scintillation counter. 
One milliliter of the filtrate was mixed with 2 ml of scintillation liquid 
and its radioactivity counted. Also the radioactivity of the washings 
was determined. The experiment was run in triplicate. In another 
experiment chymotrypsinogen, which cannot react with active-site-di- 
rected inhibitors, was treated similarly to CT. A parallel control ex- 
periment was performed in which no protein was present. 
I 
100 
80  
" • • 
, e -  
• ~ 60  
0 
0 
-~ 40 "lO 
P 
20  
I 
0.1 a2 03 
[I], 
Fig. 1. To 5 mg of horse serum BChE in 1.0 ml of 0.1 M phos- 
phate buffer pH 8 and 25 °, t-BEDEP was added to the indicated 
concentrations and the residual enzymic activity was measured. 
3. Results and discussion 
3.1. Inhibition kinetics 
When alkynyl phosphates were added to solutions of en- 
zymes of various classes it was found that only serine esterases 
and proteases were efficiently inhibited. Lysozyme, pepsin, 
alcohol dehydrogenase and lactate dehydrogenase were not 
affected. Introduction of alkynyl phosphates in excess molar 
concentration to enzyme solution resulted in time-dependent 
loss of activity until it was completely abolished. Analysis of 
the course of the inhibition reaction yielded the second-order 
specificity constant k2 = kilKi for the reaction described by 
scheme 4. 
KI ki 
E+I  <-~ E I  --~ E I  x 
Scheme 4. 
where E denotes enzyme, I the alkynyl phosphate inhibitor, EI 
the reversible enzyme-inhibitor complex with a dissociation 
constant o f / ( i ,  and ki is the rate constant of formation of 
EI x, the covalently inhibited enzyme, from El. 
The second-order inhibition rate constants for alkynyl 
phosphates are listed in Table 1. 
In many cases the rate constants listed in Table 1 exceed 
those found with conventional simple covalent inhibitors. 
Thus, the second-order rate constant of the alkynyl phos- 
phates with CT is 5.7× 104-1.8Xl0 s M -1 min -1 which is 
several fold greater than the values with other powerful inhib- 
itors of the enzyme. Phenylmethanesulfonyl fluoride (PMSF) 
and disopropyl fluorophosphate (DFP) inhibit the enzyme 
with rate constants of 18 000 and 20000 M -1 min -1, respec- 
tively [12]. Diphenylcarbamoyl chloride reacts with CT with a 
rate constant of 37000 M -~ min -1 [13], while p-nitrophenyl 
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Ta01e 1 
Second-order rate constants of the inhibition of enzymes by alkynyl phosphates (in M -1 rain -1) 
119 
Enzyme PDEP HDEP t-BEDEP DFP PARAOXON 
[10] [10] 
ct-Chymotrypsin (bovine) 5.7 x 10 4 1.8 X 10 5 8 x 10 4 2 X 10 4 9 X 10 2 
Trypsin (bovine) 3 x 10 4 
Elt:stase (porcine) 3.2 x 10 4 2.5 x 105 
Subtilisin BPN' 1.8 x 104 0.9 x 104 
Sw3tilisin Carlsberg 1.3 × 104 1.4 × 104 0.7 × 104 
Pr, ,teinase K (tritiracium album) 0.8 × 104 2.7 x 104 0.5 × 104 
T~ rombin (bovine) 1.7 × 103 1.4 × 103 
KMlikrein (porcine) 0.7 x 103 3.4 × 10 a 
Lil,ase (Candida rugosa) 3.4 × 106 5.5 × 106 3 x 106 
C1~ olesterol esterase (Pseudonomas) 0.9 × l06 7.3 × 107 1.6 × 107 
Ac .'tylcholinesterase (el ctric eel) 1.5 × 10 7 4.8 × 10 7 5 X 10 7 4.6 X 10 4 4.5 × 10 5 
Ac ~tylcholinesterase (human erythrocytes) 1.1 × 10 7 
Butyrylcholinesterase (horse serum) 4.6 x 107 4 X 107 10 x 107 1.3 x 107 1.5 x 106 
Es~erase (porcine) 0.7× 107 7.2X 107 1.8N 107 3.2X 105 7 × 106 
dkthyl phosphate (paraoxon) reacts with a rate constant of 
9;.:102 M -1 min -1 [14]. Noteworthy is the very high rate 
co astants of the inhibition of esterases, the last five enzymes 
in Table 1, which are in the range of 106-108 M -1 min -1. 
Tl~ese rates are even greater than those reported for most 
pc~vcerful phosphate inhibitors. DFP, for example, inhibits 
A~hE, BChE and esterase with rate constants of 4.6x 104, 
1. × 107 and 3.2× 105 M -1 min 1, respectively [14], and the 
ra~e constants of inhibition by paraoxon are 4.5×105, 
1." × 106 and 7X 106 M -1 min -1, respectively [14], whereas 
the, alkynyl phosphates display rate constants up to 10-100 
tiT~,es greater. Probably the active site of the esterases can 
be ter accommodate the alkynyl phosphates than the pro- 
te'. ses do, leading to a most potent inhibition. 
3.~. Titration of the active site concentration of enzymes 
~_s commercial preparations of certain enzymes are gener- 
all ¢ not pure and in some cases contain only a small portion 
of active enzyme, we utilized the powerful inhibitory capacity 
of the alkynyl phosphates to titrate the active-site concentra- 
tkn  of enzymes. A representative experiment is depicted in 
Fi~. 1. The addition of sub-equivalent amounts of 1-t-butyl 
ett ynyl diethyl phosphate to a commercial low-activity BChE 
soiution resulted in loss of activity which was directly propor- 
tic, hal to the amount of inhibitor added. The minimal concen- 
tra tion of alkynyl phosphate required to completely eliminate 
en,:ymic activity is the active-site concentration. The result of 
th~ titration indicated that the BChE contained only 0.42% 
ac ive enzyme. 
3_. Reaction with radioactively labeled alkynyl phosphate 
l'he inhibition by alkynyl phosphate can theoretically pro- 
cet:d via several mechanisms ( ee Section 1). In order to dis- 
tin guish between the different possibilities we used the radio- 
actively labeled 14C-PDEP to inhibit chymotrypsin. One 
mi ligram of the inhibited CT was precipitated with TCA, 
fihered and thoroughly washed. In a typical experiment the 
coanted radioactivity of the precipitate was 900 cpm, whereas 
the filtrates and washings had 22093 cpm, so 3.9% of the 
rat ioactivity label was found on the filter. In a parallel experi- 
ment that contained all the components of the previous one 
bu~ was devoid of CT, 0.9% of the radioactivity remained on 
the filter, indicating that the protein precipitate contained only 
3°/i of the radioactivity applied. In a control experiment we 
added alkynyl phosphate to chymotrypsinogen under identical 
conditions used in the CT inhibition. Chymotrypsinogen does 
not react with 'active' phosphates. Nevertheless the filter con- 
tained 3% of the label applied. These results indicate that only 
a negligible amount of the radioactive label was non-specifi- 
cally adsorbed to the protein, and practically the alkynyl moi- 
ety did not bind to the protein, negating mechanisms 2 and 3 
described in Section 1. The phosphate group of the alkynyl 
phosphate is therefore responsible for the high inhibitory po- 
tency of the compound. 
3.4. Reactivation of inhibited cholinesterases 
Phosphorylated cholinesterases can be reactivated by spe- 
cifically designed nucleophiles uch as pyridine aldoxime 
methiodide (PAM) [15]. We added 5 mM PAM to AChE 
inhibited by HDEP and noticed a rapid restoration of enzy- 
mic activity which was complete in a few minutes. Again, 
supporting the conclusion that phosphorylation by alkynyl 
phosphate causes the inhibition of the enzymes tudied. 
We have demonstrated that alkynyl diethyl phosphates are 
highly potent inhibitors of serine esterases and proteases. The 
triple bond adjacent to the phosphate moeity renders the al- 
kynyloxy group an excellent leaving roup when reacting with 
serine enzymes, thus leading to a rapid phosphorylation f the 
enzyme. The structure of the alkynyl moiety, which in many 
cases atisfies the specificity requirements of esterases, turn the 
alkynyl phosphates studied as most powerful covalent inhibi- 
tors of serine esterases. The present alkynyl phosphates lack 
the structural elements required for specific recognition of 
proteases' active site, nonetheless they are good inhibitors. It 
is expected that modification of alkynyl phosphates by attach- 
ing to them appropriate groups complementary to particular 
protease binding site will lead to even more efficient inhibitors. 
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